Last updated on August 2018

A Study to Assess Efficacy Safety Tolerability and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP).

Brief description of study

The purpose of this study is to assess efficacy, safety, tolerability, and pharmacokinetics of ABBV-8E12 in subjects with progressive supranuclear palsy (PSP).

Clinical Study Identifier: NCT02985879

Contact Investigators or Research Sites near you

Start Over


Q-Pharm Pty Limited /ID# 154410
Herston, Australia
  Connect »